Alliancebernstein L.P. Citius Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.65 - $1.25 $7,312 - $14,062	-11,250 Reduced 50.0%	11,250 $7,000
Q2 2023 Aug 15, 2023	BUY	$1.08 - $1.65 $24,300 - $37,125	22,500 New	22,500 $27,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $184,184 - $391,391	-209,300 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.38 - $1.89 $965 - $1,323	700 Added 0.34%	209,300 $375,000
Q2 2021 Jul 30, 2021	BUY	$1.51 - $4.23 $314,986 - $882,378	208,600 New	208,600 $726,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.